99 related articles for article (PubMed ID: 16002476)
1. Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay.
Rich IN; Hall KM
Toxicol Sci; 2005 Oct; 87(2):427-41. PubMed ID: 16002476
[TBL] [Abstract][Full Text] [Related]
2. In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates.
Olaharski AJ; Uppal H; Cooper M; Platz S; Zabka TS; Kolaja KL
Toxicol Lett; 2009 Jul; 188(2):98-103. PubMed ID: 19446241
[TBL] [Abstract][Full Text] [Related]
3. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
4. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
5. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
6. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I
Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
[TBL] [Abstract][Full Text] [Related]
7. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
Ivanović Z; Bartolozzi B; Bernabei PA; Cipolleschi MG; Milenkovic P; Praloran V; DelloSbarba P
Stem Cells; 1999; 17(4):219-25. PubMed ID: 10437985
[TBL] [Abstract][Full Text] [Related]
8. In vitro hematotoxicity testing in drug development: a review of past, present and future applications.
Rich IN
Curr Opin Drug Discov Devel; 2003 Jan; 6(1):100-9. PubMed ID: 12613281
[TBL] [Abstract][Full Text] [Related]
9. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow endothelial cell-conditional medium promotes the generation of hematopoietic colony-forming cells from murine embryonic stem cells].
Zhao HP; Lu GX; Wang QR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):192-6. PubMed ID: 18382051
[TBL] [Abstract][Full Text] [Related]
11. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines.
Bruno E; Luikart SD; Long MW; Hoffman R
Exp Hematol; 1995 Oct; 23(11):1212-7. PubMed ID: 7556532
[TBL] [Abstract][Full Text] [Related]
12. Colony-forming cells with high proliferative potential (HPP-CFC).
McNiece IK; Bertoncello I; Kriegler AB; Quesenberry PJ
Int J Cell Cloning; 1990 May; 8(3):146-60. PubMed ID: 2189013
[TBL] [Abstract][Full Text] [Related]
13. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
15. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
16. 2'3'-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopulation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow.
Irons RD; Le AT; Som DB; Stillman WS
J Clin Invest; 1995 Jun; 95(6):2777-82. PubMed ID: 7539460
[TBL] [Abstract][Full Text] [Related]
17. Developmental hematopoiesis from prenatal to young-adult life in the mouse model.
Wolf NS; Bertoncello I; Jiang D; Priestley G
Exp Hematol; 1995 Feb; 23(2):142-6. PubMed ID: 7828671
[TBL] [Abstract][Full Text] [Related]
18. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
van Pel M; Hagoort H; Hamann J; Fibbe WE
Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
[TBL] [Abstract][Full Text] [Related]
19. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.
Pessina A; Albella B; Bayo M; Bueren J; Brantom P; Casati S; Croera C; Gagliardi G; Foti P; Parchment R; Parent-Massin D; Schoeters G; Sibiril Y; Van Den Heuvel R; Gribaldo L
Toxicol Sci; 2003 Oct; 75(2):355-67. PubMed ID: 12883091
[TBL] [Abstract][Full Text] [Related]
20. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Oct; 3(10-11):1537-47. PubMed ID: 12946451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
